Atria Investments Inc Sells 2,735 Shares of Avantor, Inc. (NYSE:AVTR)

Atria Investments Inc reduced its position in shares of Avantor, Inc. (NYSE:AVTR) by 17.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,190 shares of the company’s stock after selling 2,735 shares during the quarter. Atria Investments Inc’s holdings in Avantor were worth $278,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its position in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC increased its stake in Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its holdings in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after buying an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares in the last quarter. Finally, CKW Financial Group grew its holdings in shares of Avantor by 116.7% during the fourth quarter. CKW Financial Group now owns 5,200 shares of the company’s stock valued at $110,000 after buying an additional 2,800 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on AVTR shares. Morgan Stanley lowered their target price on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Raymond James reissued an “outperform” rating and issued a $24.00 price objective (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. UBS Group reaffirmed a “neutral” rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Barclays lowered their price target on Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Finally, Royal Bank of Canada cut their price objective on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a report on Monday, February 10th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $25.50.

Avantor Price Performance

AVTR opened at $16.53 on Tuesday. The firm has a market cap of $11.25 billion, a P/E ratio of 15.89, a PEG ratio of 1.55 and a beta of 1.30. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a fifty-two week low of $15.37 and a fifty-two week high of $28.00. The firm has a 50-day moving average of $19.40 and a 200 day moving average of $21.94.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the company posted $0.22 earnings per share. On average, research analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Activity at Avantor

In other Avantor news, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.